Previous 10 | Next 10 |
home / stock / rhhbf / rhhbf news
2023-09-20 15:26:50 ET More on COVID-19 test makers Compare metrics for ABT to BDX, RHHBF Roche: Positive Readouts From Pipeline Roche: 2023 Should Mark The Bottom Abbott Laboratories: Buy This Fairly Valued Dividend King For Consistently Rising Income ...
2023-09-20 12:30:54 ET Summary Roche has optionality to grow its pipeline with selective M&A and new partnerships. The company also confirmed better pharmaceutical growth expectations. We evaluated the three biggest readouts, Elevidys, TIGIT, and Inavolisib, providing supporti...
2023-09-19 14:45:33 ET Summary Regeneron Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Tarrytown that has played a key role in the fight against COVID-19. Regeneron's revenue for the second quarter of 2023 was $3.16 billion, an increase of 10.5% compared to th...
2023-09-19 12:44:41 ET More on Scholar Rock Seeking Alpha’s Quant Rating on Scholar Rock Historical earnings data for Scholar Rock Financial information for Scholar Rock Scholar Rock: The Market Isn't Enthusiastic Despite Decent Clinical Data F...
2023-09-18 15:00:29 ET Summary Roche's stock price has declined, underperforming its peers, due to the loss of patent protection for its blockbuster drugs, lower Covid-related revenue and several pipeline setbacks. The company has developed second-generation drugs and expanded int...
2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...
2023-09-07 21:05:27 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-09-07 08:25:18 ET More on Alnylam, Roche, etc. Alnylam: Unlimited Promise Or Unlimited Losses? Alnylam Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation Alnylam Pharmaceuticals, Inc. ( ALNY ) Q2 2023 Earnings Call Transcript Roche:...
Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare Canada NewsWire The report shows digital health technologies demonstrate value, yet integrating th...
2023-09-02 14:00:00 ET More on pharma companies Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Novo Nordisk: Super Focused Pharma Company For The Long Run Regeneron Gets Boost With FDA Approval Of High-Dose Eylea (Rati...
News, Short Squeeze, Breakout and More Instantly...
Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare Canada NewsWire The report shows digital health technologies demonstrate value, yet integrating th...
Development in Alzheimer's disease diagnosis in Canada: New tests help patients and caregivers make timely decisions Canada NewsWire Roche's Cerebrospinal Fluid (CSF) assays address unmet needs in the detection of amyloid pathology by offering greater accessibility and support...